U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633743) titled 'MenoZen VR for Menopause Symptom Management: Phase 2' on June 02.
Brief Summary: The purpose of this research is to evaluate the feasibility, acceptability, tolerability, and clinical efficacy of MenoZen VR (virtual reality) for managing menopause symptoms in women.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Menopause
Intervention:
DEVICE: MenoZen
Participants will complete weekly self-administered virtual reality sessions via MenoZenVR, using a VR headset, for 8 consecutive weeks.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Mayo Clinic
Information provided by (Responsible Party): Chrisandra L. Shuf...